Kidney Stone Management Market Size, Share, and Trends 2024 to 2033

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Kidney Stone Management Market 

5.1. COVID-19 Landscape: Kidney Stone Management Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Kidney Stone Management Market, By Type of Stone

8.1. Kidney Stone Management Market, by Type of Stone, 2024-2033

8.1.1. Calcium oxalate

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Calcium phosphate

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Uric acid

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Cysteine

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. struvite

8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Kidney Stone Management Market, By Diagnostics Method

9.1. Kidney Stone Management Market, by Diagnostics Method, 2024-2033

9.1.1. Abdominal X-Ray

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Computed Tomography

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Ultrasound

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Abdominal MRI

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Intravenous Pyelography

9.1.5.1. Market Revenue and Forecast (2021-2033)

9.1.6. Others

9.1.6.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Kidney Stone Management Market, By Treatment 

10.1. Kidney Stone Management Market, by Treatment, 2024-2033

10.1.1. Extracorporeal Shock Wave Lithotripsy ESWL

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Ureteroscopy

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Percutaneous Nephrolithotomy PCNL

10.1.3.1. Market Revenue and Forecast (2021-2033)

10.1.4. Others

10.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Kidney Stone Management Market, By End-use 

11.1. Kidney Stone Management Market, by End-use, 2024-2033

11.1.1. Hospitals

11.1.1.1. Market Revenue and Forecast (2021-2033)

11.1.2. Specialty Clinics

11.1.2.1. Market Revenue and Forecast (2021-2033)

11.1.3. Ambulatory Surgical Centres

11.1.3.1. Market Revenue and Forecast (2021-2033)

11.1.4. Other

11.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 12. Global Kidney Stone Management Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.1.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.1.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.1.4. Market Revenue and Forecast, by End-use (2021-2033)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.1.5.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.1.5.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.1.5.4. Market Revenue and Forecast, by End-use (2021-2033)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.1.6.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.1.6.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.1.6.4. Market Revenue and Forecast, by End-use (2021-2033)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.2.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.2.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.2.4. Market Revenue and Forecast, by End-use (2021-2033)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.2.5.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.2.5.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.2.5.4. Market Revenue and Forecast, by End-use (2021-2033)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.2.6.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.2.6.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.2.6.4. Market Revenue and Forecast, by End-use (2021-2033)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.2.7.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.2.7.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.2.7.4. Market Revenue and Forecast, by End-use (2021-2033)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.2.8.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.2.8.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.2.8.4. Market Revenue and Forecast, by End-use (2021-2033)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.3.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.3.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.3.4. Market Revenue and Forecast, by End-use (2021-2033)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.3.5.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.3.5.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.3.5.4. Market Revenue and Forecast, by End-use (2021-2033)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.3.6.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.3.6.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.3.6.4. Market Revenue and Forecast, by End-use (2021-2033)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.3.7.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.3.7.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.3.7.4. Market Revenue and Forecast, by End-use (2021-2033)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.3.8.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.3.8.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.3.8.4. Market Revenue and Forecast, by End-use (2021-2033)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.4.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.4.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.4.4. Market Revenue and Forecast, by End-use (2021-2033)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.4.5.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.4.5.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.4.5.4. Market Revenue and Forecast, by End-use (2021-2033)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.4.6.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.4.6.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.4.6.4. Market Revenue and Forecast, by End-use (2021-2033)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.4.7.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.4.7.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.4.7.4. Market Revenue and Forecast, by End-use (2021-2033)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.4.8.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.4.8.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.4.8.4. Market Revenue and Forecast, by End-use (2021-2033)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.5.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.5.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.5.4. Market Revenue and Forecast, by End-use (2021-2033)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.5.5.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.5.5.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.5.5.4. Market Revenue and Forecast, by End-use (2021-2033)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Type of Stone (2021-2033)

12.5.6.2. Market Revenue and Forecast, by Diagnostics Method (2021-2033)

12.5.6.3. Market Revenue and Forecast, by Treatment (2021-2033)

12.5.6.4. Market Revenue and Forecast, by End-use (2021-2033)

Chapter 13. Company Profiles

13.1. Cook Medical Inc. (US)

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Boston Scientific Corporation (U.S.)

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Olympus Corp. (Japan)

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. C.R. Bard Inc. (U.S.)

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Storz Medical AG (Switzerland)

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Richard Wolf GmbH (Germany)

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Lumenis (Israel)

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. EDAP TMS (France)

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. DirexGroup (Germany)

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Elmed Electronics & Medical Industry & Trade Inc. (Turkey)

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms